Ascentage Pharma Group International (STU:36X)
€ 3.72 -0.18 (-4.62%) Market Cap: 1.43 Bil Enterprise Value: 1.46 Bil PE Ratio: 0 PB Ratio: 20.35 GF Score: 74/100

Half Year 2026 Ascentage Pharma Group International Earnings Presentation Transcript

Aug 20, 2026 / 12:00PM GMT
Release Date Price: €3.54 (-3.28%)

Aug 20, 2026 / 12:00PM GMT
Presentation
Aug 20, 2026 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Sumedh Sunkaraneni
Ascentage Pharma Group International - Investor Relations
* Dajun Yang
Ascentage Pharma Group International - Executive Chairman of the Board, Chief Executive Officer, Co-Founder
* Faical Miyara
Ascentage Pharma Group International - Global Chief Business Officer
* Jim Ziegler
Ascentage Pharma Group International - Chief Commercial Officer
* Veet Misra
Ascentage Pharma Group International - Chief Financial Officer
* Yifan Zhai
Ascentage Pharma Group International - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Brian Cheng
JPMorgan Chase & Co - Analyst
* Biren Amin
Piper Jaffray Inc - Analyst
* Jeet Mukherjee
BTIG LLC - Equity Analyst
* Gregory Renza
Truist Securities - Analyst
* Mayank Mamtani
B. Riley Securities, Inc - Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot